Risks, benefits, alternatives and indications of allogenic blood transfusions

Minerva Anestesiologica

Volumn 72, Issue 5, 2006, Pages 283-298

  Madjdpour, C ^a   Heindl, V ^a   Spahn, Donat R ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Blood; Efficacy; Guideline; Transfusion; Trigger

Indexed keywords

AMINOCAPROIC ACID; ANESTHETIC AGENT; ANTIFIBRINOLYTIC AGENT; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEMOGLOBIN; IRON; OXYGEN; OXYHEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; TRANEXAMIC ACID;

BLEEDING DISORDER; BLOOD CLOTTING; BLOOD DONOR; BLOOD VOLUME; CARDIOVASCULAR DISEASE; COLLOID; COST EFFECTIVENESS ANALYSIS; CREUTZFELDT JAKOB DISEASE; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; HEMODILUTION; HEMODYNAMIC MONITORING; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOMODULATION; INFECTION RISK; INTENSIVE CARE; IRON THERAPY; MORTALITY; ORGAN BLOOD FLOW; OXYGEN CONCENTRATION; OXYGEN SUPPLY; OXYGEN TRANSPORT; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE CARE; REVIEW; RISK BENEFIT ANALYSIS; SAFETY; SALVAGE THERAPY; SEPSIS; SURGICAL TECHNIQUE; SYMPTOM; THROMBOSIS; TREATMENT INDICATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIOVASCULAR DISEASES; CHILD; CRITICAL CARE; ERYTHROPOIETIN; HEMOGLOBINS; HEMORHEOLOGY; HUMANS; IMMUNE SYSTEM; INFANT, NEWBORN; OXYGEN; OXYHEMOGLOBINS; POSTOPERATIVE PERIOD; RISK; SEPSIS;

EID: 33646834762     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2005;95:33-42.
2. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 2004;70:15-28.
3. Madjdpour C, Marcucci C, Tissot JD, Spahn DR. Perioperative Bluttransfusion: Nutzen, Risiken und Richtlinien. Anaesthesist 2005;54:67-80; quiz 81-2.
4. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999;340:438-47.
5. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998;122:145-51.
6. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996;84:732-47.
7. Carson JL, Hill S, Carless P, Hebert P, Henry D. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002;16:187-99.
8. Meier J, Kemming GI, Kisch-Wedel H, Wolkhammer S, Habler OP. Hyperoxic ventilation reduces 6-hour mortality at the critical hemoglobin concentration. Anesthesiology 2004;100:70-6.
9. Morisaki H, Sibbald WJ. Tissue oxygen delivery and the microcirculation. Crit Care Clin 2004;20:213-23.
10. Hebert PC, Van der Linden P, Biro G, Hu LQ. Physiologic aspects of anemia. Crit Care Clin 2004;20: 187-212.
11. Weiskopf RB, Feiner J, Hopf H, Viele MK, Watson JJ, Lieberman J et al. Heart rate increases linearly in response to acute isovolemic anemia. Transfusion 2003;43:235-40.
12. Jamnicki M, Kocian R, van der Linden P, Zaugg M, Spahn DR. Acute normovolemic hemodilution: physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth 2003;17:747-54.
13. Spahn DR, Leone BJ, Reves JG, Pasch T. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 1994;78:1000-21.
14. Venn R, Steele A, Richardson P, Poloniecki J, Grounds M, Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth 2002;88:65-71.
15. Gan TJ, Soppitt A, Maroof M, el-Moalem H, Robertson KM, Moretti E et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology 2002;97:820-6.
16. Hebert PC, McDonald BJ, Tinmouth A. Clinical consequences of anemia and red cell transfusion in the critically ill. Crit Care Clin 2004;20:225-35.
17. Casutt M, Seifert B, Pasch T, Schmid ER, Turina MI, Spahn DR. Factors influencing the individual effects of blood transfusion on oxygen delivery and oxygen consumption. Crit Care Med 1999;27:2194-200.
18. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-60.
19. Hebert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997;155:1618-23.
20. DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001;71:769-76.
21. Fang WC, Helm RE, Krieger KH, Rosengart TK, DuBois WJ, Sason C et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997;96:II-194-9.
22. Hardy JF, Martineau R, Couturier A, Belisle S, Cartier R, Carrier M. Influence of haemoglobin concentration after extracorporeal circulation on mortality and morbidity in patients undergoing cardiac surgery. Br J Anaesth 1998;81 Suppl 1:38-45.
23. Hill SE, van Wermeskerken GK, Lardenoye JW, Phillips-Bute B, Smith PK, Reves JG et al. Intraoperative physiologic variables and outcome in cardiac surgery: Part I. In-hospital mortality. Ann Thorac Surg 2000;69:1070-5; discussion 1075-6.
24. Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001;29:227-34.
25. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002;42:812-8.
26. Spahn DR, Casutt M. Eliminating blood transfusions: New aspects and perspectives. Anesthesiology 2000;93: 242-55.
27. Spahn DR, Seifert B, Pasch T, Schmid ER. Effects of chronic beta-blockade on compensatory mechanisms during acute isovolaemic haemodilution in patients with coronary artery disease. Br J Anaesth 1997;78: 381-5.
28. Spahn DR, Schmid ER, Seifert B, Pasch T. Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg 1996;82:687-94.
29. Spahn DR, Smith LR, Schell RM, Hoffman RD, Gillespie R, Leone BJ. Importance of severity of coronary artery disease for the tolerance to normovolemic hemodilution. Comparison of single-vessel versus multivessel stenoses in a canine model. J Thorac Cardiovasc Surg 1994;108:231-9.
30. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-62.
31. Levy PS, Kim SJ, Eckel PK, Chavez R, Ismail EF, Gould SA et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol 1993;265:H340-9.
32. Spahn DR, Smith LR, Veronee CD, McRae RL, Hu WC, Menius AJ et al. Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow. J Thorac Cardiovasc Surg 1993;105: 694-704.
33. Spahn DR, Seifert B, Pasch T, Schmid ER. Haemodilution tolerance in patients with mitral regurgitation. Anaesthesia 1998;53:20-4.
34. Spahn DR, Zollinger A, Schlumpf RB, Stohr S, Seifert B, Schmid ER et al. Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 1996;82:681-6.
35. Hogue CW, Jr, Goodnough LT, Monk TG. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 1998;38:924-31.
36. Leung JM, Weiskopf RB, Feiner J, Hopf HW, Kelley S, Viele M et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology 2000;93:1004-10.
37. Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999;88:477-82.
38. Chassot PG, Delabays A, Spahn DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Br J Anaesth 2002;89:747-59.
39. Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth 2002;88:101-23.
40. London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology 2004;100:170-5.
41. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17.
42. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-507.
43. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E et al. The CRIT Study: Anemia and blood transfusion in the critically ill-Current clinical practice in the United States. Crit Care Med 2004;32:39-52.
44. McIntyre L, Hebert PC, Wells G, Fergusson D, Marshall J, Yetisir E et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma 2004;57:563-8; discussion 568.
45. Hebert PC, Blajchman MA, Cook DJ, Yetisir E, Wells G, Marshall J et al. Do blood transfusions improve outcomes related to mechanical ventilation? Chest 2001;119:1850-7.
46. Schonhofer B, Bohrer H, Kohler D. Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia 1998;53:181-4.
47. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-6.
48. Vincent J-L, Sakr Y, Le Gall J-R, Gerlach H, Reinhart K, Sprung C et al. Is red Blood cell transfusion associated with worse outcome? Results of the SOAP study. Chest 2003;124:125S-6S.
49. Dellinger EP, Anaya DA. Infectious and immunologic consequences of blood transfusion. Crit Care 2004;8 Suppl 2:S18-23.
50. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001;97:1180-95.
51. Vamvakas EC. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev 2002;16:304-14.
52. Vamvakas EC. WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003;43:963-73.
53. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994;34:396-401.
54. Fung MK, Rao N, Rice J, Ridenour M, Mook W, Triulzi DJ. Leukoreduction in the setting of open heart surgery: a prospective cohort-controlled study. Transfusion 2004;44:30-5.
55. Llewelyn CA, Taylor RS, Todd AA, Stevens W, Murphy MF, Williamson LM. The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion 2004;44:489-500.
56. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536-55.
57. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 1999;27:639-60.
58. Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC et al. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1998;122:130-8.
59. Goodnough LT. Risks of blood transfusion. Crit Care Med 2003;31:S678-86.
60. Wagner SJ. Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 2004;86:157-63.
61. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
62. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364: 527-9.
63. Aguzzi A, Glatzel M. vCJD tissue distribution and transmission by transfusion - a worst-case scenario coming true? Lancet 2004;363:411-2.
64. Annual report of the Chief Medical Officer 2003, available at http://www.publications.doh.gov.uk/cmo/annualreport2003/index.htm 2004.
65. Pincock S. Government confirms second case of vCJD transmitted by blood transfusion. BMJ 2004;329:251.
66. Gregori L, McCombie N, Palmer D, Birch P, Sowemimo-Coker SO, Giulivi A et al. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 2004;364:529-31.
67. Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003;17:120-62.
68. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996;36:175-86.
69. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 1999;39:701-10.
70. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999;39:694-700.
71. Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, Lachance JG et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997;63:964-7.
72. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther 2002;9:389-95.
73. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol 1999;105:322-9.
74. Serious Hazards of Transfusion Annual Report 2003. The Serious Hazards of Transfusion Steering Group, available at http://www.shotuk.org/SHOT%20Report%202003.pdf 5th July 2004.
75. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003;17:252-62.
76. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998;176:462-6.
77. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97:562-8.
78. Fergusson D, Khanna MP, Tinmouth A, Hebert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth 2004;51: 417-24.
79. Offner PJ. Age of blood: does it make a difference? Crit Care 2004;8 Suppl 2:S24-6.
80. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. Jama 1993;269:3024-9.
81. Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997;44:1256-61.
82. Leal-Noval SR, Jara-Lopez I, Garcia-Garmendia JL, Marin-Niebla A, Herruzo-Aviles A, Camacho-Larana P et al. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003;98:815-22.
83. Walsh TS, McArdle F, McLellan SA, Maciver C, Maginnis M, Prescott RJ et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 2004;32:364-71.
84. Napolitano LM, Corwin HL. Efficacy of blood transfusion in the critically ill: does age of blood make a difference? Crit Care Med 2004;32:594-5.
85. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 1999;319:16-9.
86. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999;81:2-10.
87. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332: 719-24.
88. Goodnough LT, Monk TG, Andriole GL. Erythropoietin therapy. N Engl J Med 1997;336:933-8.
89. Giarratana MC, Kobari L, Lapillonne H, Chalmers D, Kiger L, Cynober T et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005;23:69-74.
90. 2 carriers: status in 2005. Curr Pharm Des 2005 (in press).
91. Spahn DR, Kocian R. The place of artificial oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation. Can J Anaesth 2003;50: S41-7.
92. Spahn DR. Strategies for transfusion therapy. Best Pract Res Clin Anaesthesiol 2004;18:661-73.
93. Trouwborst A, Tenbrinck R, van Woerkens EC. Blood gas analysis of mixed venous blood during normoxic acute isovolemic hemodilution in pigs. Anesth Analg 1990;70:523-9.
94. Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. Jama 1998;279:217-21.
95. Hebert PC, Fergusson DA, Stather D, McIntyre L, Martin C, Doucette S et al. Revisiting transfusion practices in critically ill patients. Crit Care Med 2005;33:7-12; discussion 232-2.